# PREVAIL-TF: Transfemoral Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe)

> **NCT00820599** · NA · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 214 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** Sapien XT™ transcatheter heart valve and delivery system

## Key facts

- **NCT ID:** NCT00820599
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-12
- **Final completion:** 2016-03
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2020-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00820599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00820599, "PREVAIL-TF: Transfemoral Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00820599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*